Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: Tom D who wrote (769)	3/29/1998 12:15:00 AM
From: StockDoc	Read Replies (1) \| Respond to of 887

Dear Dr. D: In the DEPO case, you worked with incorrect data, thus your conclusions had to be incorrect too. This was not your fault as others might think. You've been fed with false information that you believed, wherever you got it from, that's all. I'm sorry. Three years of press releases and ASCO/ECCO abstracts tell the story about DepoCyt. Same drug, different results. How come? Not an NDA material, for sure. Cogito ergo sum. There is still a lot of material information coming from DEPO that could be worth reality checking. But it should not concern us any longer. I'll turn to some of your other recommended stickers. Kindest regards, StockDoc

To: Tom D who wrote (769)	3/29/1998 7:40:00 PM
From: James Silverman	Read Replies (1) \| Respond to of 887

Tom, Actually Tom, your comments helped as well as those from a Doctor I know from the Lahey Clinic outside of Boston. I asked him to run the idea (sustained release Niacin) to their cardiologists. Their conclusions were quite pessimistic hence I missed the majority of the decline. E-mail me privately if you want more in depth comments. You shouldn't let a guy like Bob bother you. His comments had no purpose other than to insult. The old adage "DO YOUR OWN HOMEWORK" applies at all times. Quite a few people owned DepoTech based in part on my recommendation and are upset at me for the Depo decline. To the #@$ with them. To blame someone else for your own investment failures is ignorance at its finest. Plenty of telltale signs were in the open here. Miljenko for one pointed out a few red flags, such as small sample size, heavy insider sales etc. That many people here chose to ignore this and not research the stock independently and draw their own conclusions was their choice. For me this debacle is something to learn from rather than to pass blame (unless you want to blame Depo for their very public overconfidence leading into the meeting). Good luck rebuilding your wealth. Regards, Jim